» Articles » PMID: 30374710

Uncoupling Protein 3 Deficiency Impairs Myocardial Fatty Acid Oxidation and Contractile Recovery Following Ischemia/reperfusion

Overview
Date 2018 Oct 31
PMID 30374710
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with insulin resistance and type 2 diabetes have poor cardiac outcomes following myocardial infarction (MI). The mitochondrial uncoupling protein 3 (UCP3) is down-regulated in the heart with insulin resistance. We hypothesized that decreased UCP3 levels contribute to poor cardiac recovery following ischemia/reperfusion (I/R). After confirming that myocardial UCP3 levels were systematically decreased by 20-49% in animal models of insulin resistance and type 2 diabetes, we genetically engineered Sprague-Dawley rats with partial loss of UCP3 (ucp3). Wild-type littermates (ucp3) were used as controls. Isolated working hearts from ucp3 rats were characterized by impaired recovery of cardiac power and decreased long-chain fatty acid (LCFA) oxidation following I/R. Mitochondria isolated from ucp3 hearts subjected to I/R in vivo displayed increased reactive oxygen species (ROS) generation and decreased respiratory complex I activity. Supplying ucp3 cardiac mitochondria with the medium-chain fatty acid (MCFA) octanoate slowed electron transport through the respiratory chain and reduced ROS generation. This was accompanied by improvement of cardiac LCFA oxidation and recovery of contractile function post ischemia. In conclusion, we demonstrated that normal cardiac UCP3 levels are essential to recovery of LCFA oxidation, mitochondrial respiratory capacity, and contractile function following I/R. These results reveal a potential mechanism for the poor prognosis of type 2 diabetic patients following MI and expose MCFA supplementation as a feasible metabolic intervention to improve recovery of these patients at reperfusion.

Citing Articles

Endoplasmic reticulum stress signaling modulates ischemia/reperfusion injury in the aged heart by regulating mitochondrial maintenance.

Zhang J, Zhao Y, Gong N Mol Med. 2024; 30(1):107.

PMID: 39044180 PMC: 11265325. DOI: 10.1186/s10020-024-00869-w.


Ferrostatin-1 specifically targets mitochondrial iron-sulfur clusters and aconitase to improve cardiac function in Sirtuin 3 cardiomyocyte knockout mice.

Cantrell A, Besanson J, Williams Q, Hoang N, Edwards K, Bishop G J Mol Cell Cardiol. 2024; 192:36-47.

PMID: 38734062 PMC: 11164624. DOI: 10.1016/j.yjmcc.2024.05.003.


Association of dietary nutrient intake with type 2 diabetes: A Mendelian randomization study.

Kang R, Guo D, Wang J, Xie Z Medicine (Baltimore). 2024; 103(19):e38090.

PMID: 38728475 PMC: 11081547. DOI: 10.1097/MD.0000000000038090.


Sex-specific colonic mitochondrial dysfunction in the indomethacin-induced rat model of inflammatory bowel disease.

Hoang N, Brooks K, Edwards K Front Physiol. 2024; 15:1341742.

PMID: 38595640 PMC: 11002206. DOI: 10.3389/fphys.2024.1341742.


Transcriptome analysis of effects of deficiency on cardiometabolic and calcium regulation in cardiac tissue.

Lin S, Chen S, Lin Q, Xiao T, Hou C, Xie L Open Med (Wars). 2024; 19(1):20230880.

PMID: 38283583 PMC: 10811529. DOI: 10.1515/med-2023-0880.


References
1.
How O, Larsen T, Hafstad A, Khalid A, Myhre E, Murray A . Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice. Arch Physiol Biochem. 2007; 113(4-5):211-20. DOI: 10.1080/13813450701783281. View

2.
Baumann R, Penketh P, Seow H, Shyam K, Sartorelli A . Generation of oxygen deficiency in cell culture using a two-enzyme system to evaluate agents targeting hypoxic tumor cells. Radiat Res. 2008; 170(5):651-60. PMC: 2667281. DOI: 10.1667/RR1431.1. View

3.
Hardy D, Clark J, Darley-Usmar V, Smith D . Reoxygenation of the hypoxic myocardium causes a mitochondrial complex I defect. Biochem Soc Trans. 1990; 18(4):549. DOI: 10.1042/bst0180549. View

4.
Irie H, Krukenkamp I, Brinkmann J, Gaudette G, Saltman A, Jou W . Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids. Proc Natl Acad Sci U S A. 2003; 100(11):6819-24. PMC: 164530. DOI: 10.1073/pnas.1132094100. View

5.
Aldakkak M, Stowe D, Chen Q, Lesnefsky E, Camara A . Inhibited mitochondrial respiration by amobarbital during cardiac ischaemia improves redox state and reduces matrix Ca2+ overload and ROS release. Cardiovasc Res. 2007; 77(2):406-15. DOI: 10.1016/j.cardiores.2007.08.008. View